<em>Clostridioides difficile</em> infection: painting a picture of prediction and prevention

1:15 PM • 4517 • Opioid treatment and outcomes of <em>Clostridioides difficile</em> infection > N. Noy MESHULAMI (New York) 1:25 PM • 2962 • A pan-European cost-of-illness analysis of patients with <em>Clostridioides difficile</em> infection: results of COMBACTE-CDI > S. Sebastian WINGEN-HEIMANN (Cologne) 1:35 PM • 3238 • Impact of testing on <em>Clostridioides Difficile</em> infection in hospitals across Europe: a mathematical model > E. Emily AGNEW (London) 1:45 PM • 3793 • A national ISO:15189 accredited <em>Clostridioides difficile</em> whole genome sequencing single-nucleotide polymorphism typing service in Wales > M. Michael PERRY (Cardiff) 1:55 PM • 4405 • Differentiation of the microbiome of patients with <em>Clostridioides difficile</em> infection, patients with non<em>-C. difficile</em> diarrhoea and <em>C. difficile</em> colonised patients > S. Silvia Noemi VÁZQUEZ-CUESTA (Madrid) 2:05 PM • 2559 • Faecal microbiota transplantation does not eradicate<em> Clostridioides difficile</em> in patients with multiple recurrent infections, despite clinical efficacy > E. Elisabeth TERVEER (Leiden) 2:15 PM • 3646 • Development of a defined bacterial consortium for the prevention of recurrent <em>Clostridioides difficile</em> infection > R. Rajita MENON (Brighton) 2:25 PM • INT90 • Q&A/Discussion